首页> 外国专利> TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FINGOLIMOD

TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FINGOLIMOD

机译:拉喹莫德和芬戈莫德联合治疗多发性硬化症

摘要

PROBLEM TO BE SOLVED: To provide: a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome; and a pharmaceutical composition for implementing the same.SOLUTION: This invention provides a method comprising administering laquinimod to a subject as an add-on therapy to fingolimod represented by formula (I) or as a combination therapy agent in combination with fingolimod. This invention also provides a package and a pharmaceutical composition for implementing the method comprising laquinimod and fingolimod for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome.SELECTED DRAWING: None
机译:要解决的问题:提供:一种治疗患有多发性硬化症或表现出临床孤立症状的受试者的方法;解决方案:本发明提供了一种方法,该方法包括将拉喹莫德作为对式(I)代表的芬戈莫德的附加治疗或作为与芬戈莫德组合的联合治疗剂给予受试者。本发明还提供了用于实施包含拉喹莫德和芬戈莫德的方法的包装和药物组合物,用于治疗患有多发性硬化症或表现出临床分离的综合症的受试者。

著录项

  • 公开/公告号JP2017137298A

    专利类型

  • 公开/公告日2017-08-10

    原文格式PDF

  • 申请/专利权人 TEVA PHARMACEUTICAL INDUSTRIES LTD;

    申请/专利号JP20170006394

  • 申请日2017-01-18

  • 分类号A61K31/4704;A61K31/137;A61P25;A61P43;A61K45;A61K39/395;A61K33/24;A61K31/56;A61K31/60;A61K31/4706;

  • 国家 JP

  • 入库时间 2022-08-21 13:59:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号